The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Nov. 03, 2016
Composition comprising diacid derivatives and their use in the treatment of collagenic eye disorders
Applicant:
The University of Liverpool, Liverpool, GB;
Inventors:
Rachel L. Williams, Liverpool, GB;
Colin E. Willoughby, Liverpool, GB;
Assignee:
The University of Liverpool, Liverpool, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/19 (2006.01); A61K 9/00 (2006.01); A61K 31/191 (2006.01); A61K 31/335 (2006.01); A61P 27/02 (2006.01); A61K 31/194 (2006.01); A61K 31/4025 (2006.01); A61K 47/18 (2017.01); A61K 47/12 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/191 (2013.01); A61K 31/194 (2013.01); A61K 31/335 (2013.01); A61K 31/4025 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61P 27/02 (2018.01);
Abstract
The present invention relates to novel pharmaceutical formulations. More specifically, the present invention relates to novel pharmaceutical formulations that are suitable for intraocular administration. The present invention also relates to the use of these formulations for the treatment of collagenic eye disorder such as, for example, the treatment of keratoconus.